Citadel Advisors - ADIAL PHARMACEUTICALS INC ownership

ADIAL PHARMACEUTICALS INC's ticker is ADIL and the CUSIP is 00688A106. A total of 24 filers reported holding ADIAL PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.82 and the average weighting 0.0%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of ADIAL PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$93,000
+232.1%
265,062
+1156.2%
0.00%
Q2 2022$28,000
-73.3%
21,100
-45.8%
0.00%
Q4 2021$105,000
+101.9%
38,900
+92.6%
0.00%
Q2 2021$52,000
-71.1%
20,198
-72.8%
0.00%
Q1 2021$180,000
+37.4%
74,291
-3.5%
0.00%
Q4 2020$131,000
+44.0%
76,971
+190.5%
0.00%
Q1 2019$91,00026,4920.00%
Other shareholders

There were no reported owners of ADIAL PHARMACEUTICALS INC in Q1 2022.

NameSharesValueWeighting ↓
View complete list of ADIAL PHARMACEUTICALS INC shareholders